docetaxel accord
accord healthcare s.l.u. - docetaxel - head and neck neoplasms, carcinoma, non-small-cell lung, adenocarcinoma, prostatic neoplasms, breast neoplasms - antineoplastic agents, - breast cancerdocetaxel accord in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with:operable node-positive breast cancer;operable node-negative breast cancer.for patients with operable node-negative breast cancer, adjuvant treatment should be restricted to patients eligible to receive chemotherapy according to internationally established criteria for primary therapy of early breast cancer.docetaxel accord in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition.docetaxel accord monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent.docetaxel accord in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer w
atosiban accord
accord healthcare limited - atosiban - solution for injection in pre-filled syringe - 6.75 milligram - atosiban
irbesartan accord
accord healthcare limited - irbesartan - film coated tablet - 150 milligram - irbesartan
irbesartan accord
accord healthcare limited - irbesartan - film coated tablet - 75 milligram - irbesartan
irbesartan accord
accord healthcare limited - irbesartan - film coated tablet - 300 milligram - irbesartan
cinacalcet accord
accord healthcare limited - cinacalcet - film coated tablet - 30 milligram - cinacalcet
cinacalcet accord
accord healthcare limited - cinacalcet - film coated tablet - 60 milligram - cinacalcet
cinacalcet accord
accord healthcare limited - cinacalcet - film coated tablet - 90 milligram - cinacalcet
olmesartan medoxomil/hydrochlorothiazide accord
accord healthcare limited - olmesartan medoxomil ; hydrochlorothiazide ep - film coated tablet - 40/12.5 milligram - olmesartan medoxomil and diuretics
topotecan accord 1mg/ml concentrate for solution for infusion
accord healthcare limited - topotecan (as hydrochloride) - concentrate for solution for infusion - 1 milligram(s)/millilitre - other antineoplastic agents; topotecan